| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Allison Swartz | EVP | 2026-09-23 | 3,903 | $26.10 | $101.87kSell |
| Geoffrey Clapp | CXO | 2026-09-17 | 819 | $27.38 | $22.42kSell |
| Kevin K. Gordon | Director | 2026-09-10 | 22,000 | $13.00 | $286.00kBuy |
| Kevin K. Gordon | Director | 2026-09-10 | 10,500 | $27.24 | $286.02kSell |
| Kevin K. Gordon | Director | 2026-09-10 | 11,500 | $27.94 | $321.36kSell |
| Kevin K. Gordon | Director | 2026-09-10 | 11,500 | $27.12 | $311.86kSell |
| Kevin K. Gordon | Director | 2026-09-10 | 10,500 | $27.24 | $286.02kSell |
| Kevin K. Gordon | Director | 2026-09-10 | 22,000 | $13.00 | $286.00kBuy |
| Kevin K. Gordon | Director | 2026-09-10 | 10,500 | $27.24 | $286.02kSell |
| Kevin K. Gordon | Director | 2026-09-10 | 11,500 | $27.94 | $321.36kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Tpg Group Holdings Sbs Advisors Inc | 13.03% | 10,000,000 | $252.30M | Insider |
| Kleiner Perkins Caufield Byers XIII LLC | 9.69% | 7,435,609 | $187.60M | Insider |
| Tpg GP A LLC | 8.28% | 6,350,000 | $160.21M | Insider |
| Glaxosmithkline PLC | 8.13% | 6,238,244 | $157.39M | Insider |
| Norman Payson | 2.43% | 1,864,265 | $47.04M | Insider |
| Karin Ajmani | 1.47% | 1,128,560 | $28.47M | Insider |
| Peter Anevski | 1.26% | 965,614 | $24.36M | Insider |
| Beth C. Seidenberg | 0.35% | 271,322 | $6.85M | Insider |
| Michael E. Sturmer | 0.33% | 255,205 | $6.44M | Insider |
| David J. Schlanger | 0.31% | 238,462 | $6.02M | Insider |